Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration

PURPOSE: The purpose of this study was to determine the impact of prophylactic ranibizumab (PR) injections given every 3 months in eyes with intermediate nonexudative age-related macular degeneration (AMD) on drusen volume, macular layer thicknesses, and progression of geographic atrophy (GA) area o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Clement K., Beaulieu, Wesley T., Lujan, Brandon J., Lalezary, Maziar, Lent-Schochet, Daniella, Lo, Therlinder, Yiu, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2023
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479187/
https://www.ncbi.nlm.nih.gov/pubmed/37656449
http://dx.doi.org/10.1167/tvst.12.9.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479187/
https://www.ncbi.nlm.nih.gov/pubmed/37656449
http://dx.doi.org/10.1167/tvst.12.9.1

Ejemplares similares